总时间（秒）：11.59
问答时间（秒）：10.06

{
    "Variants Include": [
      {
        "Gene": "TP53BP1",
        "variants": [
          {
            "HGVS": "NM_004972.3:c.674A>G",
            "cDNA Change": {
              "transcript": "NM_004972.3",
              "ref": "A",
              "alt": "G",
              "position": "674"
            },
            "Protein Change": {
              "ref": "Q225R",
              "alt": "E225G"
            },
            "Description in input context": "This variant is located in the TP53BP1 gene and causes a change from Glutamine (Q) to Arginine (R) at position 225 in the protein."
          }
        ]
      }
    ],
    "Described Disease": {
      "Described Disease": "Li-Fraumeni Syndrome",
      "MONDO": "MONDO:0012346"
    },
    "Experiment Method": [
      {
        "Assay Method": "Immunoblotting (Western Blot)",
        "Material used": {
          "Material Source": "HEK 293T cells",
          "Material Name": "HEK 293T"
        },
        "Readout type": "Quantitative",
        "Readout description": [
          {
            "Variant": "NM_004972.3:c.674A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The protein expression level was reduced by 50% for the variant NM_004972.3:c.674A>G in comparison to the wild-type control."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "Three independent biological replicates were performed for each experiment."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "Each sample was run in triplicate."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type TP53BP1 cDNA was used as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "Yes",
          "Description": "Empty vector or no insert was used as a negative control."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "Yes",
          "Counts": "2"
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "Yes",
          "Counts": "1"
        },
        "Statistical analysis method": {
          "Statistical analysis method": "One-way ANOVA followed by a post hoc test (such as Tukey's or Dunnett's) was used to compare the means of each group."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "Protein expression greater than 80% compared to wild-type.",
          "Source": "Literature"
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "Protein expression less than 50% compared to wild-type.",
          "Source": "Literature"
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      }
    ]
  }